OpenAlex
PricingAboutJobs
Log inGet started
Work

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy

HTML

Year: 2001
Type: article
Source: Blood
DOI: 10.1182/blood.v98.1.29
Authors: Andy C. Rawstron, Ben Kennedy, Paul A. S. Evans, Faith E. Davies, Stephen J. Richards, Andy P. Haynes, Nigel H. Russell, Geoff Hale, Gareth J. Morgan, Andrew S. Jack, Peter Hillmen
Institutions: Leeds General Infirmary, Nottingham City Hospital, University of Oxford
Language: English

Topic: Chronic Lymphocytic Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: chronic lymphocytic leukemia, minimal residual disease, flow cytometry assay, Campath-1H, rituximab, autologous stem cell transplantation, bone marrow disease, treatment response prediction, event-free survival, overall survival
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2132238257
FWCI: 7.857
Cites: 32
Cited by: 280
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms